Chesapeake Biological Laboratories Inc.Chesapeake...

BY THE NUMBERS

August 27, 1992

Chesapeake Biological Laboratories Inc.

Chesapeake Biological Laboratories, Inc., a Baltimore biotechnology company, reported an increase in earnings to $222,000 in the first quarter ended June 30, compared with $10,000 in the same period the year before.

The company attributed the gain to an increase in orders for two of the company's products, Vitrax, a medical device used in the eye during cataract surgery, and Equron, a drug injected into the joints of race horses to reduce the inflammation associated with arthritis.

In addition, the company said it has seen an increase in its manufacturing of sterile injectable drugs for other companies.

Revenues increased to $1.1 million from $534,000 for the same period last year.

The increase in net income included a $41,570 gain on debt restructuring.

Three months ended 6/30/92

......Revenue... .... .... Net.... .... .... Share

'92 ..1,066,000 .... .... 222,000 ... .... 0.063

....534,000 .... .... 10,000... ... .. 0.003

change +99.6... ... ... +2120.0... ... .. +2000.0

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.